An aggregation-induced emission-active lysosome hijacker: Sabotaging lysosomes to boost photodynamic therapy efficacy and conquer tumor therapeutic resistance

Therapeutic resistance is a major challenge in clinical cancer theranostics, often leading to treatment failure and increased patient mortality. Breaking this therapeutic deadlock, enhancing the efficacy of clinical treatments, and ultimately improving patient survival rates are both highly desirabl...

Full description

Saved in:
Bibliographic Details
Main Authors: Hang Zou, Pingping Wang, Zhihao Bai, Liping Liu, Jingtong Wang, Yanfang Cheng, Bairong He, Zujin Zhao, Lei Zheng
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Materials Today Bio
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S259000642500122X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856717893468160
author Hang Zou
Pingping Wang
Zhihao Bai
Liping Liu
Jingtong Wang
Yanfang Cheng
Bairong He
Zujin Zhao
Lei Zheng
author_facet Hang Zou
Pingping Wang
Zhihao Bai
Liping Liu
Jingtong Wang
Yanfang Cheng
Bairong He
Zujin Zhao
Lei Zheng
author_sort Hang Zou
collection DOAJ
description Therapeutic resistance is a major challenge in clinical cancer theranostics, often leading to treatment failure and increased patient mortality. Breaking this therapeutic deadlock, enhancing the efficacy of clinical treatments, and ultimately improving patient survival rates are both highly desirable and significantly challenging goals. Herein, we have developed a new fluorescent luminogen, QM-DMAC, which features aggregation-induced emission (AIE), and exceptional viscosity-responsive properties. The AIE-active QM-DMAC can specifically stain lysosomes in tumor cells, offering a high signal-to-noise ratio and enabling specific visualization of variations in lysosomal viscosity, such as those induced by inflammation or autophagy. Furthermore, QM-DMAC effectively generates reactive oxygen species (ROS) under white light irradiation, which precisely induces ROS-mediated lysosomal membrane permeabilization (LMP) and lysosome rupture. This ultimately causes severe cell damage and restores the sensitivity of tumor cells to radiotherapy and chemotherapy. Thus, QM-DMAC serves as a highly efficient lysosome-targeting photosensitizer and an excellent therapeutic sensitizer. This innovative “lysosome hijacking” strategy significantly maximizes the efficacy of photodynamic therapy, conquering therapeutic resistance and boosting the synergistic therapeutic effect when integrated with conventional radiotherapy or chemotherapy. It provides a novel approach to the design of theranostic agents for clinical cancer theranostics.
format Article
id doaj-art-15eb332d5eee4590a1f8c6e298d91550
institution Kabale University
issn 2590-0064
language English
publishDate 2025-04-01
publisher Elsevier
record_format Article
series Materials Today Bio
spelling doaj-art-15eb332d5eee4590a1f8c6e298d915502025-02-12T05:31:42ZengElsevierMaterials Today Bio2590-00642025-04-0131101564An aggregation-induced emission-active lysosome hijacker: Sabotaging lysosomes to boost photodynamic therapy efficacy and conquer tumor therapeutic resistanceHang Zou0Pingping Wang1Zhihao Bai2Liping Liu3Jingtong Wang4Yanfang Cheng5Bairong He6Zujin Zhao7Lei Zheng8Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China; De Feng Academy, Southern Medical University, Guangzhou, 510515, ChinaDepartment of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, ChinaDepartment of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, ChinaDepartment of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, ChinaDepartment of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, ChinaDepartment of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, ChinaDepartment of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China; De Feng Academy, Southern Medical University, Guangzhou, 510515, China; Department of Medical Laboratory, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China; Corresponding author. Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.State Key Laboratory of Luminescent Materials and Devices, Key Laboratory of Luminescence from Molecular Aggregates of Guangdong Province, South China University of Technology, Guangzhou, 510515, China; Corresponding author. State Key Laboratory of Luminescent Materials and Devices, Key Laboratory of Luminescence from Molecular Aggregates of Guangdong Province, South China University of Technology, Guangzhou, 510640, China.Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China; Corresponding author.Therapeutic resistance is a major challenge in clinical cancer theranostics, often leading to treatment failure and increased patient mortality. Breaking this therapeutic deadlock, enhancing the efficacy of clinical treatments, and ultimately improving patient survival rates are both highly desirable and significantly challenging goals. Herein, we have developed a new fluorescent luminogen, QM-DMAC, which features aggregation-induced emission (AIE), and exceptional viscosity-responsive properties. The AIE-active QM-DMAC can specifically stain lysosomes in tumor cells, offering a high signal-to-noise ratio and enabling specific visualization of variations in lysosomal viscosity, such as those induced by inflammation or autophagy. Furthermore, QM-DMAC effectively generates reactive oxygen species (ROS) under white light irradiation, which precisely induces ROS-mediated lysosomal membrane permeabilization (LMP) and lysosome rupture. This ultimately causes severe cell damage and restores the sensitivity of tumor cells to radiotherapy and chemotherapy. Thus, QM-DMAC serves as a highly efficient lysosome-targeting photosensitizer and an excellent therapeutic sensitizer. This innovative “lysosome hijacking” strategy significantly maximizes the efficacy of photodynamic therapy, conquering therapeutic resistance and boosting the synergistic therapeutic effect when integrated with conventional radiotherapy or chemotherapy. It provides a novel approach to the design of theranostic agents for clinical cancer theranostics.http://www.sciencedirect.com/science/article/pii/S259000642500122XAggregation-induced emissionTherapeutic resistancePhotodynamic therapyTherapeutic sensitizerLysosomal membrane permeabilization
spellingShingle Hang Zou
Pingping Wang
Zhihao Bai
Liping Liu
Jingtong Wang
Yanfang Cheng
Bairong He
Zujin Zhao
Lei Zheng
An aggregation-induced emission-active lysosome hijacker: Sabotaging lysosomes to boost photodynamic therapy efficacy and conquer tumor therapeutic resistance
Materials Today Bio
Aggregation-induced emission
Therapeutic resistance
Photodynamic therapy
Therapeutic sensitizer
Lysosomal membrane permeabilization
title An aggregation-induced emission-active lysosome hijacker: Sabotaging lysosomes to boost photodynamic therapy efficacy and conquer tumor therapeutic resistance
title_full An aggregation-induced emission-active lysosome hijacker: Sabotaging lysosomes to boost photodynamic therapy efficacy and conquer tumor therapeutic resistance
title_fullStr An aggregation-induced emission-active lysosome hijacker: Sabotaging lysosomes to boost photodynamic therapy efficacy and conquer tumor therapeutic resistance
title_full_unstemmed An aggregation-induced emission-active lysosome hijacker: Sabotaging lysosomes to boost photodynamic therapy efficacy and conquer tumor therapeutic resistance
title_short An aggregation-induced emission-active lysosome hijacker: Sabotaging lysosomes to boost photodynamic therapy efficacy and conquer tumor therapeutic resistance
title_sort aggregation induced emission active lysosome hijacker sabotaging lysosomes to boost photodynamic therapy efficacy and conquer tumor therapeutic resistance
topic Aggregation-induced emission
Therapeutic resistance
Photodynamic therapy
Therapeutic sensitizer
Lysosomal membrane permeabilization
url http://www.sciencedirect.com/science/article/pii/S259000642500122X
work_keys_str_mv AT hangzou anaggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT pingpingwang anaggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT zhihaobai anaggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT lipingliu anaggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT jingtongwang anaggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT yanfangcheng anaggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT baironghe anaggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT zujinzhao anaggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT leizheng anaggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT hangzou aggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT pingpingwang aggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT zhihaobai aggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT lipingliu aggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT jingtongwang aggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT yanfangcheng aggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT baironghe aggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT zujinzhao aggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance
AT leizheng aggregationinducedemissionactivelysosomehijackersabotaginglysosomestoboostphotodynamictherapyefficacyandconquertumortherapeuticresistance